3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Curaxis Pharmaceutical's 3-Year ROIIC % for the quarter that ended in Dec. 2011 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Curaxis Pharmaceutical's 3-Year ROIIC % or its related term are showing as below:
CURXQ's 3-Year ROIIC % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.29 * Ranked among companies with meaningful 3-Year ROIIC % only.
Curaxis Pharmaceutical 3-Year ROIIC % Historical Data
The historical data trend for Curaxis Pharmaceutical's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Curaxis Pharmaceutical 3-Year ROIIC % Chart
Curaxis Pharmaceutical Annual Data
Trend
Dec08
Dec09
Dec10
Dec11
3-Year ROIIC %
-
-
-
-
Curaxis Pharmaceutical Semi-Annual Data
Dec08
Dec09
Dec10
Dec11
3-Year ROIIC %
-
-
-
-
Competitive Comparison of Curaxis Pharmaceutical's 3-Year ROIIC %
For the Drug Manufacturers - General subindustry, Curaxis Pharmaceutical's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaxis Pharmaceutical's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaxis Pharmaceutical's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Curaxis Pharmaceutical's 3-Year ROIIC % falls into.
Curaxis Pharmaceutical 3-Year ROIIC % Calculation
Curaxis Pharmaceutical's 3-Year ROIIC % for the quarter that ended in Dec. 2011 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -1.922 (Dec. 2011) - -0.017 (Dec. 2008) )
/
( 4.093 (Dec. 2011) - 0.001 (Dec. 2008) )
=
-1.905
/
4.092
=
-46.55%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Curaxis Pharmaceutical 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Curaxis Pharmaceutical's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description
Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CURXQ has been successfully added to your